Thus, memory CD8(+) T cells might be a promising predictor in cancer patients with immunotherapy.<h4>Conclusions</h4>The host's overall immune status, and not only the tumor itself, should be considered to predict the efficacy of immunotherapy in cancer patients. The gene discussed is CD8A; the disease is cancer.